Canada markets closed

BriaCell Therapeutics Corp. (BCT.TO)

Toronto - Toronto Real Time Price. Currency in CAD
Add to watchlist
1.0500-0.2000 (-16.00%)
At close: 03:59PM EDT
Currency in CAD

Valuation Measures4

Market Cap (intraday) 22.86M
Enterprise Value 21.58M
Trailing P/E 730.70
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)16.97
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA -1.87

Trading Information

Stock Price History

Beta (5Y Monthly) 1.91
52-Week Change 3-85.26%
S&P500 52-Week Change 323.23%
52 Week High 310.2900
52 Week Low 30.9900
50-Day Moving Average 31.8829
200-Day Moving Average 34.4090

Share Statistics

Avg Vol (3 month) 37.75k
Avg Vol (10 day) 35.15k
Shares Outstanding 518.28M
Implied Shares Outstanding 619.02M
Float 813.04M
% Held by Insiders 115.56%
% Held by Institutions 112.04%
Shares Short (Jun 28, 2024) 41.05k
Short Ratio (Jun 28, 2024) 40.14
Short % of Float (Jun 28, 2024) 40.01%
Short % of Shares Outstanding (Jun 28, 2024) 40.01%
Shares Short (prior month May 31, 2024) 43.29k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3Jan 02, 2020
Ex-Dividend Date 4N/A
Last Split Factor 21009:1000
Last Split Date 3Sept 05, 2023

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Jul 31, 2023
Most Recent Quarter (mrq)Apr 30, 2024


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-122.71%
Return on Equity (ttm)N/A

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA -35.25M
Net Income Avi to Common (ttm)-6M
Diluted EPS (ttm)-0.5100
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)935.69k
Total Cash Per Share (mrq)0.05
Total Debt (mrq)N/A
Total Debt/Equity (mrq)N/A
Current Ratio (mrq)0.82
Book Value Per Share (mrq)-0.37

Cash Flow Statement

Operating Cash Flow (ttm)-31.01M
Levered Free Cash Flow (ttm)-17.95M